10 results
Endoscopy in Barrett's Esophagus - Scoping Summary
- What we need to know?
   • Risk
Risk Factors ... Follow-up • ACG ... - Endoscopic Treatment ... diagnosis #management #algorithm
Hyperkalemia - Management Algorithm
 • IV calcium
 • IV insulin and glucose and/or salbutamolt
 • Consider
Hyperkalemia - Management Algorithm ... Dialysis Serum potassium ... and ECG changes ... , Prolonged PR interval ... #treatment
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
dependent DM ACS ... algorithm to determine ... indicated • EKG ... Obtain EKG if: ... • <12mo since ACS
Emergent Hyperkalemia Treatment Algorithm
ECG changes, weakness, K+ >6.5 Or renal insufficiency with K >5.5 with cellular
Emergent Hyperkalemia Treatment ... Algorithm ECG ... injury, etc) ECG ... Remove potassium ... #Algorithm #Management
Algorithm for choosing the appropriate candidate for stress testing in patients with suspected coronary artery disease
Algorithm for choosing ... metabolic equivalent; ECG ... diagnosis and risk ... evaluation of stable ... #ACS #stresstest
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Indication: Reduce risk ... tablet once daily ... increase to 500 mcg ... recommendations for the treatment ... to reduce the risk
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Risk Factors and ... during Delivery • Stable ... no consensus on risk ... Risk of recurrence ... management #cardiology #treatment
Medications for the Treatment of Hyperkalemia
The goals of acute treatment are to prevent potentially life-threatening cardiac
goals of acute treatment ... hyperkalemia, changes on ECG ... patients are at risk ... Figure 3 is an algorithm ... hyperkalemia, and Table
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
heparinized tube) • ECG ... depress, ↑PR ↑QRS intervals ... Elimination (see Table ... - IVF as ... #potassium #nephrology
The chemical formula of Digoxin is C41 H64 O14.
Digoxin (Cardiac glycoside) reversibly inhibits the sodium-potassium-ATPase, causing
increasing frequency as ... particularly important risk ... effect" on the ECG ... inversion), QT interval ... the successful treatment